The head of the U.S. Food and Drug Administration’s drug division, Dr. George F. Tidmarsh, resigned on November 2, 2025, one ...

The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, ...

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on ...

George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...

Dr. George Tidmarsh, the head of the Food and Drug Administration’s drug center, abruptly resigned Sunday amid concerns about ...

The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, while safe, ...

An alleged extortion attempt, a petty yearslong grudge, shocking social media posts, and ominous text messages make up the ...

(Reuters) -Bristol Myers Squibb reached a $239 million settlement of claims that former Celgene shareholders were defrauded ...